Please assess the completion status of the following clinical trial:

Trial Title: Does Noninvasive Electrical Stimulation of Acupuncture Points (NESAP) Reduce Heelstick Pain in Infants?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Newborn infants born at 37-42 weeks gestational age~* Less than 3 days of age~* Requiring a heelstick for clinically indicated blood sampling~* Written, informed consent from their parents.~Exclusion Criteria:~* Newborns who have received any analgesic treatment~* Exposed to chronic opiates in utero (excluding opiates given only at the time of delivery) or with a positive drug screen based on review of medical records.~* Current maternal cigarette smoking.~* Infants exposed to birth asphyxia (5-minute Apgar scores of \<5 or cord pH \<7.0).~* Infants on mechanical ventilation.~* Newborns with suspected or confirmed neuromuscular diseases, congenital anomalies, or sepsis.~* Infants with birth trauma to the lower extremities (bruising or other) or those exposed multiple heelsticks in the previous 24 hours (e.g. requiring frequent glucose or bilirubin measurements).~* Infants born from mothers with drug addiction, diabetes, pre-eclampsia, or systemic inflammatory conditions.~* Abnormal neurological exam~* Congenital heart defects~* Enrollment or participation in other studies~* Dermatologic condition in the area of electrode placement or elsewhere~* Local or systemic infection documented or suspected~* Reasonable known allergy to the gel/adhesive~* Bleeding abnormality~* Connection to other medical equipment or devices that might interfere with the workings or functioning of the transcutaneous electrical nerve stimulation (TENS) unit~* Any condition the investigator determines will put the subject at risk if participating in the study.

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 3 Days
- Healthy Volunteers: t

Study Arms:
- Sham NESAP with 24% oral sucrose (Type: EXPERIMENTAL): 1. Sham NESAP: Four Stim Care electrodes with gel backing will be placed on the infant's lower leg at acupuncture points. However, the Empi Select TENS unit will not be turned on. The TENS unit will be hidden from investigators so that they are blinded to the status of the unit.~2. Infant will receive 1 ml of 24% oral sucrose solution given along with a pacifier two minutes before the heel stick. Investigators will be blinded to the solution given.
- NESAP with oral water (Type: EXPERIMENTAL): 1. NESAP: Four Stim Care electrodes with gel backing will be placed on the infant's lower leg at acupuncture points. 10 minutes before the heel stick, the Empi Select TENS unit will be turned on with settings 3.5mA, 10 Hz. The TENS unit will be hidden from investigators so that they are blinded to the status of the unit.~2. Infant will receive 1 ml of sterile water given via oral syringe along with a pacifier two minutes before the heel stick. Investigators will be blinded to the solution given
- NESAP with 24% oral sucrose (Type: EXPERIMENTAL): 1. NESAP: Four Stim Care electrodes with gel backing will be placed on the infant's lower leg at acupuncture points. The Empi Select TENS unit will be turned on ten minutes before the heel stick at settings 3.5 mA, 10 Hz. The TENS unit will be hidden from investigators so that they are blinded to the status of the unit.~2. Infant will receive 1 ml of 24% oral sucrose solution given along with a pacifier two minutes before the heel stick. Investigators will be blinded to the solution given.
- Sham NESAP with oral water (Type: PLACEBO_COMPARATOR): 1. Sham NESAP: Four Stim Care electrodes with gel backing will be placed on the infant's lower leg at acupuncture points. However, the Empi Select TENS unit will not be turned on. The TENS unit will be hidden from investigators so that they are blinded to the status of the unit.~2. Infant will receive 1 ml of sterile water given via oral syringe along with a pacifier two minutes before the heel stick. Investigators will be blinded to the solution given.

Based on this trial design, predict the completion outcome and termination type (if applicable).